Back to ALLO

Allogene Therapeutics, Inc. 8-K

Accession 0001628280-26-034583

Filing information

CIK
0001737287
Report date
2026-05-12
Filing date
2026-05-13
Form
8-K
Primary document
allo-20260512.htm

Open primary document

View the filing document on sec.gov.

Open EDGAR directory

Inspect all files for this filing.

Complete submission file

Open the raw SEC submission text.